Colistin forKlebsiella pneumoniae–Associated Sepsis
- 1 January 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 38 (1), e7-e9
- https://doi.org/10.1086/380461
Abstract
Klebsiella pneumoniae that was resistant to all available antibiotics (minimum inhibitory concentration of imipenem, 32 µg/mL), including carbapenems, was isolated from blood samples obtained from a 48-year-old patient in the intensive care unit. The patient developed septic shock, which was successfully treated with colistin, the only antibiotic with activity against this multidrug-resistant strain.Keywords
This publication has 13 references indexed in Scilit:
- Treatment of Multidrug‐ResistantAcinetobacter baumanniiVentilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAPClinical Infectious Diseases, 2003
- Extended Spectrum ??-Lactamase (ESBL)-Producing EnterobacteriaceaeDrugs, 2003
- Colistin: An Antimicrobial for the 21st Century?Clinical Infectious Diseases, 2002
- Klebsiella and Enterobacter: Antibiotic resistance and treatment implicationsSeminars in Respiratory Infections, 2002
- Antimicrobial Resistance in Gram-Negative Isolates from European Intensive Care Units: Data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) ProgrammeJournal of Chemotherapy, 2002
- Outbreak of Infection with Multidrug-Resistant Klebsiella pneumoniae Carrying bla IMP-8 in a University Medical Center in TaiwanJournal of Clinical Microbiology, 2001
- Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs)Clinical Microbiology & Infection, 2000
- High incidence of Klebsiella pneumoniae clinical isolates to extended-spectrum B-lactam drugs in intensive care unitsDiagnostic Microbiology and Infectious Disease, 2000
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999
- A reassessment of the in-vitro activity of colistin sulphomethate sodiumJournal of Antimicrobial Chemotherapy, 1997